function

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

Source Node:
Time Stamp: February 7, 2024 10:46 AM - Modified On: February 7, 2024 - Published By:
Source Cluster:
Republished By Plato

Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio industry welcomed the parliament’s passage of a bill that adds regenerative medicine organizations to the list of those considered for human cell management business licenses. The National Assembly passed the “Amendment to the Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals” in a plenary session paving the way for certain next generation NK Cell Therapy companies to recognized as a licensed

Blueberry Protocol Launches High-Leverage DeFi Hub Optimized For Liquidity Access and Risk Control

Source Node:
Time Stamp: January 23, 2024 12:25 PM - Modified On: January 23, 2024 - Published By:
Source Cluster:
Republished By Plato

[PANAMA CITY, PANAMA] January 23, 2024 – Blueberry Protocol today announces the launch of its decentralized prime brokerage terminal, delivering industry-leading Loan-to-Value (LTV) ratios of up to 20x for optimized on-chain trading and yield strategies. Blueberry is the first protocol to enable decentralized access to generalized leverage models with leverage on Ethereum and offers an increasing value opportunity with more sophisticated security management and higher leverage than traditional prime brokerage. By merging innovative and transparent risk management instruments with an advanced leverage architecture, Blueberry aims to broaden accessibility, increase efficiency,

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

My Life As A Science Experiment ; Continues

Source Node:
Time Stamp: September 11, 2023 1:03 PM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

A year ago Every=Ten of Ten doctors told me with confidence that I would Not get better and could not survive with Kidney function of 4.1% and Creatinine of 12.32. Immediate dialysis leading to a hopeful transplant or; death. I rejected every doctors advice and had this idea that for as long as I can I would reverse engineer manually all the vital functions that kidneys influence. It's 13 months later and I function well using frequent blood tests to tweak my protocol. It's a 24/7 job with 20+ pills

My Health Manifesto : Cracking The Code : Flying Solo

Source Node:
Time Stamp: September 11, 2023 12:31 PM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

Today when I Google "how long can a person live with my GFR 5% / kidney function the answer was "a few hours to a few weeks without dialysis." In a study with 8000+ patients 65+ with similar numbers; a month was the survival time. @68 (Stage 5 kidney failure is less than 15% /GFR; I'm not even anywhere on/near the chart) As I enter my Fourteenth/14th month; I am Defiantly hopeful. positive and optimistic that My Miracle will continue. #notmytimetodie #superoutlier While I challenge this death sentence I feel better and clearer

Welcome Renal Warriors

Source Node:
Time Stamp: September 11, 2023 7:57 AM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

Stablecoins Under Scrutiny

Source Node:
Time Stamp: July 1, 2023 9:36 AM - Modified On: July 1, 2023 - Published By:
Source Cluster:
Republished By Plato

Amidst the market’s recovery from the recent onslaught of SEC crackdowns, rumors swirl over the potential targeting of stablecoins in their crosshairs. Such a move could have profound implications for cryptocurrency prices, making it crucial to gauge the likelihood of this scenario and the approach regulators might adopt. The largest stablecoins by market cap are Tether’s USDT and Circle’s USDC. Both are pegged to the US dollar and backed by various assets, typically highly liquid instruments like US Treasury bills. In theory, when someone wants to buy stablecoins from an

BREATHE! Convention Launches Unprecedented NFT Ticketing Function for Attendees Using NFT-TiX Marketplace

Source Node:
Time Stamp: March 28, 2023 8:15 AM - Modified On: March 28, 2023 - Published By:
Source Cluster:
Republished By Plato

For Immediate Release March 28, 2023 LAS VEGAS, NV - BREATHE! Convention, the highly anticipated Web3 convention, is proud to announce the launch of its NFT ticketing function, powered by the NFT-TiX platform. This cutting edge blockchain ticketing platform is fully built and designed to revolutionize the ticketing industry by providing long-term solutions against fraud, scalping, and an out-of-control secondary market. "We wanted to offer our attendees an easy, and secure solution to purchase and collect tickets with functionality, pre-during-post event. Through our partnership with NFT-TiX, not only are we